Matrix Metalloproteinase-1 as an Independent Prognostic Biomarker in Epithelial Ovarian Carcinoma
Serum MMP-1 concentration may serve as a poor prognostic biomarker in ovarian cancer. Its use alongside CA125 could enhance prognostic assessment.
Authors
- Yasuhiro Kazuki (ORCID: https://orcid.org/0000-0003-4818-4710)
- Fuminori Taniguchi
- Mayumi Sawada
- Hiroyuki Kugoh (ORCID: https://orcid.org/0000-0001-5404-3063)
- Tasuku Harada (ORCID: https://orcid.org/0000-0002-1492-7275)
- Genki Hichiwa
- Shinya Sato (ORCID: https://orcid.org/0000-0002-2155-2379)
- Kanako Kazuki
- Hiroaki Komatsu (ORCID: https://orcid.org/0000-0002-4507-6848)
- Masayo Okawa (ORCID: https://orcid.org/0000-0001-9952-8793)
- Kohei Hikino
- Koji Yamamoto
- Yuki Iida (ORCID: https://orcid.org/0000-0001-9714-3013)
- Mitsuo Oshimura
Institutions
- Tottori University (JP)
Publication Details
- Journal
- Anticancer Research
- Published
- 2025-09-26
- DOI
- https://doi.org/10.21873/anticanres.17795
- Primary Topic
- Protease and Inhibitor Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.00